Pre-exposure HIV prophylaxis in Russia: market analysis for 2022

Posted on


Pre-exposure HIV prophylaxis in Russia market analysis for 2022

The incidence and prevalence of HIV infection, as well as HIV mortality in Russia are among the highest among the countries of EECA (Eastern Europe and Central Asia). In Russia and in many other countries, including in the EECA region, there is an outflow of HIV into the general population (heterosexual contacts, partners of representatives of the key risk groups). The number of new HIV infections in Russia has been consistently high over the past few years. To successfully counteract the spread of HIV, modern integrated approaches to preventive and anti-epidemic measures for HIV infection are needed. One of the extremely effective ways to prevent HIV transmission is through pre-exposure prophylaxis (PrEP).

The main objective of the study is to assess the existing market of pre-exposure prophylaxis of HIV (PrEP) in Russia.

The objectives of the study are to analyze access to PrEP, analyze the demand for PrEP at all levels (state, commercial, non-commercial), establish the availability of PrEP programs and their financing, review legislation and regulations in the field of pre-exposure prophylaxis.

Based on the results of the study, conclusions were drawn about the current situation with access to PrEP in the Russian Federation and recommendations were developed to improve the accessibility
of PrEP.

Please note that the analysis was completed in April-May 2023.